Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...

SAB Biotherapeutics Inc (SABS) reports significant progress in its SAB142 program despite increased R&D and G&A expenses, maintaining a strong cash position to support future growth.

FDA fast track designation enables increased regulatory interaction and potential rolling BLA review for RPTR-1.201 in ...

Bivalent EABR mRNA boosters broaden neutralizing responses to Omicron subvariants by promoting diverse receptor-binding domain epitope targeting, although antibody responses remain partially shaped by ...

Objectives Smoking is recognised as one of the strongest environmental risk factors for the development of rheumatoid ...

Despite successfully removing amyloid plaques from the brain, widely anticipated antibody therapies fail to deliver meaningful cognitive improvements, raising critical questions about the future ...

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study Patients with advanced ...

We read with great interest the recent article by Tsai et al,1 which compared characteristics between primary neuromyelitis ...

Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial). A DNA plasmid melanoma cancer vaccine ...

Scientists just took a step toward developing a therapy that could prevent someone from getting measles after they have been ...

Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of ...